Position in TMO
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$506,373
-$73,140 QoQ
Shares Held
1,010
-14.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,743
of 2,606 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Trilogy Capital Inc. holds $506,373 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,010 | $506,373 |
All Filings in TMO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $506,373 | 1,010 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $579,513 | 1,179 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $770,089 | 1,329 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $653,806 | 1,348 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $540,072 | 1,332 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $750,380 | 1,508 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $781,385 | 1,502 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $930,329 | 1,504 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $856,044 | 1,548 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $291,767 | 502 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $236,201 | 445 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $232,838 | 460 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $231,657 | 444 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $242,075 | 420 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $245,057 | 445 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $203,383 | 401 | Shares | Sole | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||